SURGISENSE CORPORATION

Basic Information

5272 River Road
Suite 200
Bethesda, MD, -

http://www.surgisense.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 783945384
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence

    Amount: $1,750,986.00

    DESCRIPTION (provided by applicant): Standard of care for surgical resection of rectal cancer is the performance of low anterior resection (LAR). After removal of the cancerous segment, a surgical sta ...

    SBIR Phase II 2012 Department of Health and Human Services
  2. Device to Improve Treatment of Colorectal Cancer Using O2 Dependent Phosphorescen

    Amount: $228,501.00

    DESCRIPTION (provided by applicant): Anastomotic failure is one of the most feared complications of gastrointestinal surgery due to the resultant morbidity and mortality. Failure of an anastomosis, or ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. A Device to Reduce Anastomotic Failure in the Treatment of Colorectal Cancer

    Amount: $199,385.00

    DESCRIPTION (provided by applicant): Anastomotic failure is one of the most feared complications of gastrointestinal surgery due to the resultant morbidity and mortality. Failure of an anastomosis, or ...

    SBIR Phase I 2009 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government